HTT and Huntington disease: However, the recent failure of trials of the antisense oligonucleotide tominersen, aimed at reducing the “toxic” level of huntingtin (HTT) protein, possibly suggests that the “causal” role of HTT in this monogenic disease is hypothetical, and thus, that further studies are required to determine the neurodegenerative mechanisms associated with HD [35].